Federal Register notice: FDA announces the renewal of its Oncologic Drugs Advisory Committee for an additional two years beyond the charter expiration...
A Boston federal judge sentences former co-owner of now-closed New England Compounding Center, Gregory Conigliaro, to one year in prison for his role ...
President Biden signs into law HR 8454, the Medical Marijuana and Cannabidiol Research Expansion Act.
FDA sends Y-mAbs Therapeutics a complete response letter on its BLA for I-omburtamab and its use in treating CNS/leptomeningeal metastasis from neurob...
FDA lifts a clinical hold against Beam Therapeutics and its BEAM-201 for treating relapsed/refractory T-cell acute lymphoblastic leukemia/T-cell lymph...
FDA sends Cutera a Warning Letter related to marketing material that appeared on a company owned Web site about uncleared gynecological indications, i...
A Medtronic Dear Doctor letter describes a potential issue with the driveline cover in its HeartWare Ventricular Assist Device.
Lilly says its investigational Alzheimers drug donanemab outperformed Biogens Aduhelm in clearing brain amyloid in a Phase 3 comparator study.
